FactorPad
Build a Better Process

Stock Risk Measures for Intercept Pharmaceuticals In

A quantitative factor review as of June 30, 2021.
  1. Company Info - Description, identity and sector data.
  2. Share Data - Stock earnings and key dates.
  3. Market Risk - Beta, size, liquidity and momentum measures.
  4. Financial Risk - Earnings and dividends.
face pic by Paul Alan Davis, CFA
Updated: July 06, 2021
See how we arrive at an overall risk score of 83 for ICPT below.

/ factorpad.com / stocks / f21gpr.html


An ad-free and cookie-free website.


ICPT Risk Report

Overview

Our quantitative data points are meant to provide a high-level understanding of factors in equity risk models for Intercept Pharmaceuticals In. Portfolio managers use these models to forecast risk, optimize portfolios and review performance.

We show how ICPT stock compares to 2,000+ US-based stocks, and to peers in the Manufacturing sector and Pharmaceutical Preparation Manufacturing industry.

Please do not consider this data as investment advice. Data is downloaded from sources we deem reliable, but errors may occur.

Company Info

Business Description

Company logo Intercept is a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, including primary biliary cholangitis (PBC) and nonalcoholic steatohepatitis (NASH). Founded in 2002 in New York, Intercept has operations in the United States, Europe and Canada.

Identity

Sector and Industry

Share Data

Shares

Earnings and Dividends

Market Risk Measures

Many of the following risk metrics are standardized and transformed into quantitative factors in institutional-level risk models.

Rankings below represent percentiles from 1 to 100, with 1 being the lowest rating of risk.

Systematic Risk

Stocks with higher beta exhibit higher sensitivity to the ups and downs in the market. (↑↑)

Company Size

Stocks with higher market capitalization often have lower risk. (↑↓)

Trading Liquidity

Higher average daily dollar volume over the past 30 days implies lower liquidity risk. (↑↓)

Price Momentum

Higher price momentum stocks, aka recent winners, equate to lower risk for many investors. (↑↓)

Financial Risk Measures

Style risk factors often include measures of profitability and payout levels.

Earnings Yield

Companies with higher earnings generally provide lower risk. (↑↓)

Dividend Yield

Companies with higher dividend yields, if sustaintable, are perceived to have lower risk. (↑↓)

/ factorpad.com / stocks / f21gpr.html


ICPT stock risk
INTERCEPT PHARMACEUTICALS IN stock beta
ICPT risk report
ICPT f21gpr
ICPT risk analysis
ICPT volatility
INTERCEPT PHARMACEUTICALS IN credit risk
ICPT liquidity risk
ICPT leverage
ICPT valuation
ICPT systematic risk
ICPT specific risk
INTERCEPT PHARMACEUTICALS IN volatility
ICPT analysis
ICPT financial ratio

A newly-updated free resource. Connect and refer a friend today.